| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 02/19/2009 | WO2009023269A2 4-(9-(3, 3-difluorocyclopentyl) -5, 7, 7-trimethyl-6-oxo-6, 7, 8, 9-tetrahydro-5h-pyrimido [4, 5-b[1, 4] diazepin-2-ylamino)-3-methoxybenzamide derivatives as inhibitors of the human protein kinases plk1 to plk4 for the treatment of proliferative diseases |
| 02/19/2009 | WO2009023253A2 IMIDAZO[L,2-α]PYRIDINE DERIVATIVES AS MODULATORS OF THE 5-HT2A SEROTONIN RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO |
| 02/19/2009 | WO2009023251A1 Methods and compositions for treating neural degeneration |
| 02/19/2009 | WO2009022961A1 Pyrrolopyridine derivatives and their use as bace inhibitors |
| 02/19/2009 | WO2009022934A1 Intranasal pharmaceutical compositions comprising succinic acid and methods thereof |
| 02/19/2009 | WO2009022933A1 Pharmaceutical compositions for intranasal administration comprising choline salts of succinic acid |
| 02/19/2009 | WO2009022932A1 Pharmaceutical compositions comprising monocholine succinate salts |
| 02/19/2009 | WO2009022756A1 Diagnosis and treatment of ischemic disease |
| 02/19/2009 | WO2009022731A1 P2x4 receptor antagonist |
| 02/19/2009 | WO2009022730A1 P2x4 receptor antagonist |
| 02/19/2009 | WO2009022687A1 Phenylacetic acid compound |
| 02/19/2009 | WO2009022633A1 Bicyclic acylguanidine derivative |
| 02/19/2009 | WO2009022345A1 Phenyl carbamates for the treatment of multiple sclerosis |
| 02/19/2009 | WO2009022311A2 1,2-diamido-ethylene derivatives as orexin antagonists |
| 02/19/2009 | WO2009022098A1 Amino acid derivatives |
| 02/19/2009 | WO2009022068A2 Medicament for treating parkinson's disease |
| 02/19/2009 | WO2009022067A2 Medicament for treating parkinson's disease |
| 02/19/2009 | WO2009022066A2 Novel naphthalene derivatives, process for the preparation thereof and pharmaceutical compositions containing same |
| 02/19/2009 | WO2009022065A2 Novel naphthalene derivatives, process for the preparation thereof and pharmaceutical compositions containing same |
| 02/19/2009 | WO2009022064A2 Novel naphthalene derivatives, process for the preparation thereof and pharmaceutical compositions containing same |
| 02/19/2009 | WO2009022063A2 Novel naphthalene derivatives, process for the preparation thereof and pharmaceutical compositions containing same |
| 02/19/2009 | WO2009021991A1 Use of r(+)-alpha-lipoic acid for cryptogenic neuropathy |
| 02/19/2009 | WO2009021961A1 Pyrazoloquinoline and pyrazolonaphthyridine derivatives as gaba alpha ligands |
| 02/19/2009 | WO2009021957A2 Tricyclic heterocyclic compounds as gaba a modulators |
| 02/19/2009 | WO2009021926A2 Use of a neurotoxin |
| 02/19/2009 | WO2009001040A3 Treatment of depression |
| 02/19/2009 | WO2008157408A3 Use of prodrugs of gaba analogs, antispasticity agents, and prodrugs of gaba b receptor agonists for treating spasticity |
| 02/19/2009 | WO2008157404A3 Derivatives of 4-(n-azacycloalkyl) anilides as potassium channel modulators |
| 02/19/2009 | WO2008157356A3 Antibody formulations |
| 02/19/2009 | WO2008155533A3 Phenothiazine compounds for treating mild cognitive impairment |
| 02/19/2009 | WO2008151637A3 Neuroplastin derived peptides |
| 02/19/2009 | WO2008144320A3 Opioid and methods of making and using the same |
| 02/19/2009 | WO2008130630A3 Polymorphic form of rimonabant hydrochloride and processes for preparation thereof |
| 02/19/2009 | WO2008111590A3 Ampa and nmda receptor antagonists for neurodegenerative diseases |
| 02/19/2009 | WO2008109856A3 Methods of using diazepinone compounds in treating sodium channel-mediated diseases or conditions |
| 02/19/2009 | WO2008100560A3 Estrogen receptor modulators, associated pharmaceutical compositions and methods of use |
| 02/19/2009 | WO2008063842A3 Methods of treating neuropathic pain with agonists of ppar-gamma |
| 02/19/2009 | WO2008060364A3 Humani zed antibody against amyloid beta |
| 02/19/2009 | WO2008018827A8 Benzimidazole derivatives useful in treatment of vallinoid receptor trpv1 related disorders |
| 02/19/2009 | WO2008017753A3 Pharmaceutical composition containing saredutant and a selective inhibitor of serotonin recapture or an inhibitor of serotonin/norepinephrine recapture in combination |
| 02/19/2009 | WO2007075772A3 Compounds, screens, and methods of treatment |
| 02/19/2009 | US20090048447 Method for decreasing opioid metabolism |
| 02/19/2009 | US20090048348 Method for treating autism |
| 02/19/2009 | US20090048336 Escitalopram oxalate powders |
| 02/19/2009 | US20090048326 Azabicycloheptyl compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptor |
| 02/19/2009 | US20090048323 such as 1-cyclohexyl-5-{4-[dimethylamino-(3-fluorophenyl)-methyl]-cyclohexyl}-4-isobutyl-4,5-dihydro-1H-imidazole-4-carboxylic acid methyl ester, used to treat pain, depression, urinary incontinence, diarrhea, pruritus, alcohol and drug misuse, drug dependency, lethargy and/or anxiety |
| 02/19/2009 | US20090048321 Benzimidazole Derivatives and Their Use for Modulating the GABA-Alpha Receptor Complex |
| 02/19/2009 | US20090048320 Used to treat beta -amyloid deposits and neurofibrillary tangles, including Alzheimer's disease, Trisomy 21 (Down's Syndrome), Hereditary Cerebral Hemorrhage with Amyloidosis of the Dutch-type (HCHWA-D), and other neurodegenerative disorders. |
| 02/19/2009 | US20090048306 Pyridine derivatives |
| 02/19/2009 | US20090048300 Heterocyclic Compounds |
| 02/19/2009 | US20090048296 High concentration local anesthetic formulations |
| 02/19/2009 | US20090048295 Substituted 5,6,7,8-tetrahydroquinoline derivatives, compositions, and methods of use thereof |
| 02/19/2009 | US20090048290 2s,3r)-n-(2-((3-pyridinyl)methyl)-1-azabicyclo[2.2.2]oct-3-yl-benzyofuran-2-carboxamide, novel salt forms, and methods of use thereof |
| 02/19/2009 | US20090048288 Method of treating stress-mediated depression |
| 02/19/2009 | US20090048285 Pyrrolopyridines Useful in the Treatment of Inflammation |
| 02/19/2009 | US20090048284 Therapeutic compounds |
| 02/19/2009 | US20090048283 Salt of an androgen receptor modulator |
| 02/19/2009 | US20090048272 Preparation of paliperidone |
| 02/19/2009 | US20090048263 neuroprotectants such as 4-biphenyl-3-yl-N-pyridin-3-ylpiperazine-1-carboxamide effective in prevention and treatment of cerebrovascular disorders such as necrosis, hemorrhages, injuries, as antidepressants and/or anxiolytic agents |
| 02/19/2009 | US20090048256 1-(2-chlorophenyl)-5-(4-chlorophenyl)-4-methoxy-3-[N-(1-azacycloheptyl)-carbamoyl]-1H-pyrazole, useful for treatment of nervous system disorders |
| 02/19/2009 | US20090048249 3-benzoimidazolyl-pyrazolopyridines useful in treating kinase disorders |
| 02/19/2009 | US20090048238 Novel biaryl derivatives |
| 02/19/2009 | US20090048237 Compositions and methods for procedural sedation and analgesia using oral transmucosal dosage forms |
| 02/19/2009 | US20090048236 New phenylalanine derivatives |
| 02/19/2009 | US20090048233 Enhancing the Tolerability of a Seratonin Antagonist and a NSRI, a SNRI or a RIMA by Using Them in Combination |
| 02/19/2009 | US20090048232 Compositions and methods for prophylaxis and treatment of addictions |
| 02/19/2009 | US20090048229 Methods for promoting wakefulness |
| 02/19/2009 | US20090048228 Heterocycle Derivatives As Histone Deacetylase (Hdac) Inhibitors |
| 02/19/2009 | US20090048226 Inhibitors of caspases |
| 02/19/2009 | US20090048225 Histamine h3 receptor agents, preparation and therapeutic uses |
| 02/19/2009 | US20090048224 Compounds and methods of use |
| 02/19/2009 | US20090048215 Compositions for Ameliorating a Reduced Higher Brain Function Resulting From Organic Brain Lesions |
| 02/19/2009 | US20090048213 Prodrug of cinnamide compound |
| 02/19/2009 | US20090048200 GPR 26 G-Protein Coupled Receptor |
| 02/19/2009 | US20090048185 Therapeutic Drug for Suppressing Functions of NKT Cells Containing Glycolipid Derivative as Active Ingredient |
| 02/19/2009 | US20090048172 Neuroprotective dietary supplement |
| 02/19/2009 | US20090048169 Identification of Crmp4 as a Convergent Regulator of Axon Outgrowth Inhibition |
| 02/19/2009 | US20090048149 Antagonists of the bradykinin B1 receptor |
| 02/19/2009 | US20090047741 Compositions and methods comprising a ligand of chemerin R |
| 02/19/2009 | US20090047370 Topical treatment of peripheral neuropathy |
| 02/19/2009 | US20090047325 Xenotransplant for cns therapy |
| 02/19/2009 | US20090047315 Porous magnesia and process for preparing the same |
| 02/19/2009 | US20090047305 Method of producing proanthocyanidin oligomer |
| 02/19/2009 | US20090047258 Compositions and methods for reversing age-related changes in extracellular matrix proteins |
| 02/19/2009 | US20090047234 Compositions for nasal delivery |
| 02/19/2009 | US20090047217 Polynucleotides Encoding Members of the Human B Lymphocyte Activation Antigen B7 Family and Polypeptides Encoded Thereby |
| 02/19/2009 | DE102007038849A1 Verwendung von R(+)-alpha-Liponsäure zur Behandlung der kryptogenen Neuropathie Use of R (+) - alpha-lipoic acid for the treatment of neuropathy cryptogenic |
| 02/19/2009 | DE102007038015A1 Verwendung eines Neurotoxins Use of a neurotoxin |
| 02/19/2009 | CA2702292A1 Bicyclic amides for ehancing glutamatergic synaptic responses |
| 02/19/2009 | CA2696404A1 Therapeutic compounds |
| 02/19/2009 | CA2696349A1 Heterocyclic inhibitors of necroptosis |
| 02/19/2009 | CA2696012A1 Derivatives of 5-amino-4,6-disubstituted indole and 5-amino-4,6-disubstituted indoline as potassium channel modulators |
| 02/19/2009 | CA2695757A1 Phenylacetic acid compound |
| 02/19/2009 | CA2695753A1 Compounds useful as protein kinases inhibitors |
| 02/19/2009 | CA2695636A1 Bicyclic acylguanidine derivative |
| 02/19/2009 | CA2695456A1 3' substituted compounds having 5-ht6 receptor affinity |
| 02/19/2009 | CA2694993A1 1,2-diamido-ethylene derivatives |
| 02/19/2009 | CA2694209A1 Azepine derivatives as gamma-secretase inhibitors |
| 02/19/2009 | CA2691593A1 Novel naphthalene derivatives, process for the preparation thereof and pharmaceutical compositions containing same |
| 02/19/2009 | CA2691586A1 Novel naphthalene derivatives, process for the preparation thereof and pharmaceutical compositions containing same |